Itraconazole-associated adverse events in fungal infections: a study of a large real-world sample based on the FAERS database (2019–2024)

Alice in wonderland syndrome: Down the rabbit hole of VigiBase®

Comparative Accuracy, Stability, and Correctability of Large Language Models in Otolaryngology and Pharmacovigilance

Anesthesia Drug Shortages: Crisis Management in the Operating Room

Adverse drug reactions monitoring in the third trimester pregnant women from rural population of central India visiting tertiary care hospital: A cross- sectional pharmacovigilance study.

A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine

Differential Analysis of Neonatal Adverse Drug Events from Intrauterine and Extrauterine Exposure: Insights into Administration Routes Using the FAERS Database

Physiological and metabolomic insights into the toxicity mechanisms of antipsychotic drug chlorpromazine hydrochloride on Microcystis aeruginosa

Cytopenias as Adverse Drug Reactions: A 10-Year Analysis of Reporting Structure, Rate, and Trend

Adverse Drug Reaction to Linezolid in Drug-Resistant Tuberculosis: A Systematic Review

Real-World Data on Severe Cutaneous Adverse Reactions to Drugs

Pharmacovigilance practices for new drugs in Thailand: A situation analysis in tertiary and university hospitals

Unmeasured Corticosteroid Burden May Mask Safety Signals in Herbal Medicine Users: A Call for Dosage Adjustment

Pharmacomicrobiomics in Hepatobiliary Disease: The Role of the Gut Microbiota in Drug Disposition and Safety

Improvements of an Oral Anti-cancer Drug Safety Management Program for Patients with Cancer

THE DARK PRESCRIPTION: INSIDE THE INFRASTRUCTURE OF ILLEGAL ONLINE PHARMACIES

Artificial intelligence in medication management and drug dosing in critical care

Microbiotoxicity: an under-recognised player in drug efficacy, toxicity, and health outcomes

Medication Errors Disproportionately Affect Vulnerable Populations

Machine learning prediction of pediatric adverse drug reactions using consensus-derived scarce data

La AEMPS informa sobre la retirada del mercado de un lote de Blokium-Diu 100 mg/25 mg comprimidos por un defecto de calidad

A Hybrid Pharmacovigilance Method for National-Scale Comorbidity Discovery: Association Rules with FDA-Approved PRR/Chi-square and EBGM Validation.

A real-world pharmacovigilance study of modafinil events in the FDA Adverse Event Reporting System (FAERS)

Neurological drugs induced congenital anomalies: A pharmacovigilance analysis of neonatal reports in the FDA adverse event reporting system (FAERS)

Complex chronic adverse events following immunization: a systemic critique and reform proposal for vaccine pharmacovigilance

Intelligent Counterfeit Detection Through Hybrid Pattern Mining and Blockchain Traceability: A Drug Distribution Case Study

Revisiting the Anti-Drug Antibody Assay Drug Tolerance of a Commercial Biological Product

Disproportionality analysis of Satralizumab in FDA Adverse Event Reporting System and Japanese Adverse Drug Event Report: a pharmacovigilance study

Does Enforcement of Drug Regimen Reviews Improve Medication Safety and Management in Nursing Homes? An Analysis of the CMS Drug Regimen Review Policy

Unlicensed medical practice as a public health risk: Implications for Korean Medicine

Systematic review and meta-analysis of chemotherapy-induced adverse drug reactions among children with cancer in Africa

Resistencia a antibióticos: un problema muy preocupante, especialmente en edades pediátricas

Methadone, Buprenorphine May Lower Opioid Overdose Risk

The effect of a police crackdown on online drug sales: on the importance of targeting vendors’ reputation?

Liver Toxicity: Structural Knowledge May Help Avoiding Rare Drug Adverse Events

Cytopenias as Adverse Drug Reactions: A 10-Year Analysis of Reporting Structure, Rate, and Trend

Boletín sobre Seguridad de Medicamentos de Uso Humano. Octubre de 2025

Orchestrating generative AI in pharmacovigilance: predicting and preempting the unpredictable

Del paciente al ecosistema: la farmacovigilancia en el contexto de la farmacoecología

Antidepressant medications: a comprehensive review of efficacy, safety, and future directions

Transformer-based models for ADR detection: cross-drug validation and benchmarking against large language models

Analysis of Drug Product Dispensing Error Characteristics, Construction and Evaluation of a Risk Warning Model in Outpatient Pharmacy: A Retrospective Study in China

Proton Pump Inhibitors Under Scrutiny: How Real Is the Risk?

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine

Healthcare regulator suggests simple winter wellness choices to keep you safe this cough and cold season

Identification of the consequences of the proliferation of counterfeit sports supplements market

Counterfeit Medicine Knowledge and Practices among Dental and Pharmacy Faculty–A South Indian Questionnaire Study

Medication Errors Review and Prevention Strategies

Intervenidos 70.000 medicamentos en 20 maletas facturadas en el aeropuerto Tenerife Norte

Fedratinib in chronic kidney disease: antifibrotic potential and renal safety signals from integrated network toxicology and pharmacovigilance

Therapeutic Ineffectiveness of Calcitonin Gene-Related Peptide Antagonists: A Real-World Pharmacovigilance Analysis

Artificial intelligence in oncology drug development and management: a precision medicine perspective

Differential risk of adverse drug reactions with baricitinib across age groups: integrating real-world pharmacovigilance and genetic causal inference

Drug-Induced Intestinal Angioedema: A Disproportionality Analysis Using the United States Food and Drug Administration Adverse Event Reporting System Database and Literature Review

Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System

Disproportionality analysis of Atrial Fibrillation associated with Direct Oral Anticoagulants: A Pharmacovigilance study using the Food and Drug Administration Adverse Event Reporting System database

Pharmacovigilance Investigation of Tyrosine Kinase Inhibitors: Evaluation of Adverse Events

Post-Marketing Safety of Tazemetostat in Antitumor Therapy: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System

Control administrativo en farmacovigilancia: logros y desafíos en el Instituto Nicaragüense de Seguridad Social, Nicaragua 2024.

“Trends and challenges in adverse drug reaction reporting in Spain: Analysis of the FEDRA database (2019–2023)”

Abuse liability of dextromethorphan and its combinatory formulation dextromethorphan/bupropion: a pharmacologic perspective

Hypersensibilité médicamenteuse chez les bovins. Récit du traitement d'un signal en pharmacovigilance vétérinaire

Assessing DDI risks in drug discovery and development: approaches, challenges, and trends

Drug-drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors

Ethiopia Launched National Strategy to Combat Substandard and Falsified Medical Products (2026–2030)

Pharmacovigilance Due Diligence in Drug Development: A Practical Playbook for Risk Identification, Compliance Assessment, and Strategic Decision Making

La AEMPS informa de la detección en el mercado europeo de unidades falsificadas de la prueba de autodiagnóstico COVID-19 and Influenza A+B Antigen Combo Rapid Test

OPS y ANMAT avanzan en la conformación de una red federal de farmacovigilancia en Argentina

Veterinary Drug Residues in Food Chains: Sources, Exposure Pathways, Health Impacts, Mitigation, and Safety Assurance

Research and practice on key drug safety monitoring under the normalization of centralized procurement: A case study of 13 selected drugs in a Province

A real-world pharmacovigilance study of FDA adverse event reporting system events for cefazolin

Guillain–Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance study

Drug toxicity deaths associated with opioid agonist treatment: An analysis of methadone and buprenorphine-related fatalities in Victoria, Australia

Hospitalization linked to antiepileptics, sedative-hypnotics and anti-Parkinsonian drug poisoning, adverse effects, and underdosing in Australia: An ecological study

ISP incorporará la terminología MedDRA al Sistema de Vigilancia Integrada (SVI) para el reporte de eventos adversos

Safety of Drugs Used in Difficult-to-Treat Epileptic Syndromes: A Disproportionality Analysis Using the Eudravigilance Database

Pattern, Severity, and Preventability of Adverse Drug Reactions in a Tertiary-Care Hospital: Insights from Central India

Nuevo método de tecnovigilancia para dispositivos de estimulación eléctrica transcorneal

Leveraging Large Language Models for Adverse Drug Event Detection: A Comparative Study of Token and Span-Based Named Entity Recognition

Adverse drug event signal detection and risk factor analysis of blinatumomab in ten years of post-marketing use

Chinese Herbal Medicine in Pediatric Oncology: Effects on Survival and Toxicity – A Meta-analysis

Nonfatal Drug Overdose in a National Sample of Adolescents by Intent and Substance, Medicaid 2016-2020

Trial-Based Costs for Interventions to Improve HPV Vaccine Uptake

High-Risk Penicillin Reaction Flags in the Medical Record

Contraceptive Tied to Higher Brain Tumor Risk in Women

A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs

Medical Product Alert N°7/2025: Falsified IBRANCE (palbociclib)

Leveraging the Lanham Act for anti-counterfeiting: A case study of Gilead Sciences' successful civil-to-criminal enforcement strategy in the US pharmaceutical market

Blockchain and Artificial Intelligence in Pharmaceutical Supply Chain Traceability: A Systematic Review

Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidance

The impact of artificial intelligence-driven decision support on uncertain antimicrobial prescribing: a randomised, multimethod study

WHO and the European Commission expand partnership to combat antimicrobial resistance

Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism

Precision pharmacovigilance integrates genomics and real world evidence to overcome drug safety barriers

Diseases are not treated with words, but with medicines. Setting up galenic laboratories in Africa

Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the Clinical Practice Research Datalink (CPRD)

A Patient Needs a Drug. They Have Their Own Ideas. What Now?

Towards interprofessional medication safety risk management: a qualitative interview study for physicians in primary and secondary care

Exposing Vulnerabilities in Counterfeit Prevention Systems Utilizing Physically Unclonable Surface Features

Evaluating and Optimizing Machine Learning Models to Predict Drug Side Effects

Recent Advances on Thermochromic Inks for Security Applications

Disproportionality and time-to-onset analyses of drug-induced weight gain using the Japanese Adverse Drug Event Report database

Improving Pharmacovigilance via Systematic GASS Screening and Interdisciplinary Collaboration in the Outpatient Setting

Real world based on FAERS database: To explore the mining and analysis of adverse pregnancy events related to drug exposure

Comparative Real-World Safety Profiles of Six Selective Serotonin Reuptake Inhibitors: A Global Pharmacovigilance Analysis

Pharmacovigilance assessment of adverse events following yellow fever vaccination: Disproportionality analysis of VAERS reports, 2015–2025

Assessment of Pharmacovigilance Practices in Primary Healthcare Facilities in Nasarawa State, Nigeria

Enhancing Medication Safety with LLMs

Safety of Herbal Medicine in the Postpartum Period: A Hospital-Based Single-Arm, Prospective Observational Study (SAFEHERE-PC)

Role of Metabolites in Drug-Drug Interactions

Placebo in controlled clinical trials

Engagement and Awareness in the Age of Memes

Spain’s Rise in Off-Label Doxycycline Use for Sexually Transmitted Infections

ISMP Announces New Medication Safety Best Practices

A Single-Center Prospective Study on Adverse Drug Reactions Associated With Polypharmacy in Elderly Outpatients

A Survey of Knowledge, Attitude, and Practice of Reporting of Adverse Drug Reactions by Indian General Population

Artificial Intelligence-driven prediction of Drug–Herb Interactions: A critical need in India’s pluralistic health culture and Pharmacovigilance framework

Digital monitoring in the Ayush Pharmacovigilance for safer health care

A meta-contrastive learning approach for clinical drug-drug interaction extraction from biomedical literature

The promise of cardiomyocyte computational models for drug safety

Prescribed Drugs and Interpersonal Violence: A Case–Non-Case Study in the Spanish Pharmacovigilance Database

Large Language Models for Drug-Related Adverse Events in Oncology Pharmacy: Detection, Grading, and Actioning

Assessment of pharmacovigilance awareness and adverse drug reaction reporting among hospital pharmacists: A nationwide survey

Peligros de la desinformación relacionada con la cardiología en las redes sociales

Estudio del Hospital Clínico Universidad de Chile alerta por resistencia a fármacos contra el VIH

Commission presents new EU Drugs Strategy and Action Plan against drug trafficking to protect citizens and disrupt criminal networks

Antibiotic-induced adverse drug reactions: investigating the utility of routinely collected data

Detection and Management of Signals Associated with Adverse Drug Reactions from Atorvastatin and Rosuvastatin: An Observational Study

Comparative Safety Profiles of Spironolactone, Eplerenone, and Finerenone: A Pharmacovigilance Study Based on FAERS Data from 2004 to 2024

Selection of Local Journals for Medical Literature Monitoring in Poland for Pharmacovigilance. Standard of the Polish Society of Pharmacovigilance–replication study

Machine learning methods for predicting adverse drug events: A systematic review

Pharmacovigilance in the field of addiction: challenges and emerging solutions

Pharmacovigilance assessment of ropivacaine safety using FAERS data (2004–2024)

Peripheral Neuropathy Associated With Proteasome Inhibitors and Immunomodulatory Drugs: A Pharmacovigilance Disproportionality Analysis Using VigiBase

Real-World Evidence for Medicare Drug Price Negotiations

Knowledge, practices, and recognition ability of counterfeit medicines among lebanese community pharmacists during concurrent national crises

La industria farmacéutica valora el posicionamiento del Consejo de la UE sobre la Ley de Medicamentos Críticos

pvEBayes: An R Package for Empirical Bayes Methods in Pharmacovigilance

Las farmacias sevillanas contarán con un servicio especializado en seguridad de medicamentos

Safety considerations for patients using cannabis

A real-world safety analysis of infection-related adverse events associated with belimumab, rituximab, and TNF inhibitors using the FAERS database

Vaccinating in the Shoulder: Why Needle Length Matters

Prediction of Pregnancy-Related Adverse Drug Reactions from Chemical Conformers Using a Fractional-Pooling Dilated CNN

World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

Knowledge, practices, and recognition ability of counterfeit medicines among lebanese community pharmacists during concurrent national crises

Patient and family experiences inform antidepressant safety information review

Striking the Balance: Evidence-Based versus Defensive Medicine

GLP-1 RAs: warnings aligned over potential risk of suicidal thoughts or behaviours

Prevalence, associated factors, and safety implications of prehospital herbal medicine use in Southwestern, Ethiopia

The role of community pharmacy professionals in combating Counterfeit and substandard drugs in the Amhara regional state, Ethiopia

COFEPRIS registra más de 77 mil reportes de vigilancia sanitaria en 2025

UNICEF alerta de que la brecha en el tratamiento del VIH pone en peligro a millones de niños

Quality Indicators for Drug Dispensing in Community Pharmacies: A Scoping Review Protocol

A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use

Enhancing Patient Education on Safe Crushing of Hazardous Oral Medications for Patients With Swallowing Difficulties at Home

Drug-induced immune-mediated uveitis: a real-world pharmacovigilance analysis using FAERS and JADER databases

Adverse Drug Reactions and Drug Interactions in Multimorbid Patients: A Review of Current Evidence

A Hybrid System for Comprehensive and Consistent Automated MedDRA Coding of Adverse Drug Events

Don't License AI to Prescribe Medication — A bill in Congress confuses device clearance with medical judgment

Could dedicated pharmacists help improve neonatal care’s medicines safety problem?

A popular “essential” medicine may be putting unborn babies at risk

Indecopi informa sobre nuevos riesgos en el uso del fentanilo alertados por la Digemid

Global epidemiology of vaccine-associated intussusception in children and adolescents, 1968 to 2024: An international pharmacovigilance study